Don't worry, HCQ info's a click away
The move will likely ease the worries of thousands of Indians who have been prescribed the drug for certain ailments — including malaria and autoimmune disorders like rheumatoid arthritis and lupus — but are facing difficulty in getting it after India lifted a ban on its export last week.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news
More News: Arthritis | Biotechnology | India Health | Lupus | Malaria | Pharmaceuticals | Rheumatoid Arthritis | Rheumatology